A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HRS-3802 Monotherapy in Patients With Malignant Solid Tumors
A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HRS-3802 Monotherapy in Patients With Malignant Solid Tumors
Recruiting · NCT06770569 · Registry updated 2026-03-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HRS-3802 Monotherapy in Patients With Malignant Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 | 2026-03-30 | NCT06770569 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shandong Suncadia Medicine Co., Ltd. | 37 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing | China | 71 |
| GenesisCare North Shore (Oncology) | Saint Leonards | Australia | 1 |
| GenesisCare St Andrews | Adelaide | Australia | 1 |
| John Flynn Private Hospital | Tugun | Australia | 4 |
| Macquarie University Hospital | Sydney | Australia | 9 |
| Peninsula and South Eastern Haematology & Oncology Group | Frankston | Australia | 3 |